MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Atypical progression of motor symptoms in Facio-Scapulo-Humeral Dystrophy: clinical worsening or overlap?

    D. Calisi, M. de Rosa, M. Russo, A. Thomas, M. Onofrj, S. Sensi (Chieti, Italy)

    Objective: This case highlights the importance of considering possible overlaps with PSP and other neurodegenerative diseases. Background: Facio-Scapulo-Humeral Dystrophy is a common muscular dystrophy featuring…
  • 2023 International Congress

    What change to expect in duration of benefit per dose when switching from IR CD-LD to IPX203 (ER CD-LD)

    R. Hauser, S. Allard, G. Banisadr, S. Fisher (Tampa, USA)

    Objective: To investigate if duration of benefit (“Good On” time) per dose during immediate-release (IR) carbidopa-levodopa (CD-LD) treatment predicts response to IPX203 conversion. Background: Levodopa’s…
  • 2023 International Congress

    Circuit-based targeting for closed-loop deep brain stimulation for Tourette Syndrome

    C. Butson, A. Gunduz, K. Foote, E. Mahoney-Rafferty, J. Gomez, M. Hook, J. Cagle, G. Lowor, U. Suryadevara, D. Bowers, I. Malaty, W. Allen, M. Okun (Gainesville, USA)

    Objective: To assess the safety, feasibility, neurophysiology and neuroimaging-driven targeting of the centromedian thalamus (CM) and anterior globus pallidus internus (aGPi) for deep brain stimulation…
  • 2023 International Congress

    Closed-loop gait improvement in Parkinson’s Disease

    P. Kirsch, M. Helbig, S. Baudrexel, C. Kell (Frankfurt am Main, Germany)

    Objective: The aim of this study was to measure gait parameters of patients with Parkinson’s Disease (PD) in everyday life situations and improve hypokinetic gait…
  • 2023 International Congress

    Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease.The AMBITIOUS Study Protocol

    F. Colucci, M. Avenali, R. de Micco, A. Bacila, S. Cerri, G. Cuconato, V. Franco, D. Franciotta, C. Ghezzi, M. Gastaldi, C. Galandra, G. Germani, P. Mitrotti, G. Ongari, I. Palmieri, M. Picascia, A. Pichiecchio, F. Esposito, M. Cirillo, F. Di Nardo, S. Aloisio, M. Siciliano, M. Fusar Poli, M. Stanziano, B. Garavaglia, F. Cazzaniga, C. Reale, I. Tramacere, S. Priori, P. Amami, S. Piacentini, MG. Bruzzone, M. Grisoli, F. Moda, R. Eleopra, A. Tessitore, EM. Valente, R. Cilia (Milan, Italy)

    Objective: To determine in Parkinson’s disease (PD) patients carrying GBA mutation the role of Ambroxol (ABX) on the progression of cognitive performance (primary aim), motor…
  • 2023 International Congress

    The neurological manifestations of PHARC syndrome: a systematic review

    V. Mendes Ferreira, M. Magriço, P. Bugalho, B. Meira, R. Barbosa (Lisboa, Portugal)

    Objective: To provide a systematic review of the neurological manifestations of the PHARC syndrome. Background: Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts (PHARC) syndrome…
  • 2023 International Congress

    Prevalence and severity of non-motor symptoms in hispanic at-risk population with REM-sleep behavior disorder.

    E. Argüelles-González, A. Jorge-de Sarachaga, R. Solís-Vivanco, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To detect non-motor symptoms in individuals at-risk for Parkinson's disease (PD) due to idiopathic REM sleep behavior disorder (RBD) and determine the rate of…
  • 2023 International Congress

    Treatment of chorea in pediatric subjects with pallidal and thalamic deep brain stimulation

    J. Maclean, A. Salisbury, J. Olaya, M. Liker, T. Sanger (Orange, USA)

    Objective: Assess the utility of deep brain stimulation (DBS) in treatment of chorea in pediatric patients. Background: While DBS has become common in treatment of…
  • 2023 International Congress

    Quantitative Evaluation of Seborrheic Dermatitis in Patients with Autonomic Dysfunction.

    R. Sengoku, A. Nakahara, T. Kitagawa, M. Ikeda, H. Matsuno (Tokyo, Japan)

    Objective: We quantitatively evaluated skin condition of patients with autonomic dysfunction. Background: Dyshidrosis are known to be one of autonomic symptom in Lewy body disease…
  • 2023 International Congress

    Common oscillatory patterns between Parkinson’s disease and heroin dependent patients: a resting-state EEG study

    D. Benis, V. Fleury, P. Krack (Geneva, Switzerland)

    Objective: We aimed to compare resting-state EEG oscillations between Parkinson’s disease (PD) patients during their ON and OFF Dopamine Replacement Therapy (DRT) states, heroin-dependent (HD)…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley